Oncology Venture ApS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oncology Venture ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11230
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal cancer, liver cancer, prostate cancer, multiple myeloma, and others. It provides gene-tumor-technology for identifying patients with resistance to anticancer drug. Oncology Venture’s activities include in-licensing drugs with low response rate performing phase II trials on a selected population and identifying the ones that are positive for its proprietary biomarker; and out-licensing the drugs with high response rate. It conducts research and development to discover new drugs. The company partners with other pharmaceutical companies to co-develop oncology drugs. Oncology Venture is headquartered in Hoersholm, Denmark.

Oncology Venture ApS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncology Venture ApS, Medical Devices Deals, 2012 to YTD 2018 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 11
Venture Financing 12
Oncology Venture Raises USD4 million in Seed Financing 12
Oncology Venture Raises USD0.56 Million in Venture Financing 13
Merger 14
Oncology Venture to Merger with Medical Prognosis Institute 14
Licensing Agreements 15
Oncology Venture Exercises Option to In-License Dovitinib with Novartis Pharma 15
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 16
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 17
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 18
Equity Offering 19
Oncology Venture Raises USD1 Million in Private Placement of Shares 19
Oncology Venture ApS – Key Competitors 20
Oncology Venture ApS – Key Employees 21
Oncology Venture ApS – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Aug 31, 2018: Oncology Venture announce publication of financial report for January – June 2018 23
Other Significant Developments 24
Nov 01, 2018: Oncology Venture provides clinical up-date 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Oncology Venture ApS, Pharmaceuticals & Healthcare, Key Facts 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncology Venture ApS, Deals By Therapy Area, 2012 to YTD 2018 8
Oncology Venture ApS, Medical Devices Deals, 2012 to YTD 2018 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 11
Oncology Venture Raises USD4 million in Seed Financing 12
Oncology Venture Raises USD0.56 Million in Venture Financing 13
Oncology Venture to Merger with Medical Prognosis Institute 14
Oncology Venture Exercises Option to In-License Dovitinib with Novartis Pharma 15
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 16
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 17
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 18
Oncology Venture Raises USD1 Million in Private Placement of Shares 19
Oncology Venture ApS, Key Competitors 20
Oncology Venture ApS, Key Employees 21

List of Figures
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncology Venture ApS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Oncology Venture ApS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tetra Technologies, Inc.
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • UNeMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Unemed Corp (Unemed), a subsidiary of University of Nebraska Medical Center, is a healthcare service provider. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup formation and licensing process. Its technologies include therapeu …
  • Arbor Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Arbor Pharmaceuticals LLC (Arbor) is a healthcare products provider that develops prescription products for the hospital, cardiovascular and pediatric segments. The company offers licensing, manufacturing, development and commercialization of late-stage prescription products. It also offers …
  • Aspire Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aspire Health Inc (Aspire) is a healthcare company which operates a network of outpatient palliative care practices providing medical care for patients with relief from the symptoms, pain, and stress of a serious illness. Its service offerings include symptom and disease management, in-home …
  • Seadrill Limited (SDRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Seadrill Limited (Seadrill) is an offshore drilling contractor. The company provides contract drilling, well services and engineering services to offshore exploration and production companies. Its fleet includes drillships, jack-up rigs, semi-submersibles, and tender rigs for operations in s …
  • Sompo Japan Nipponkoa Holdings, Inc.:戦略・SWOT・企業財務分析
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Bank Saint Petersburg:企業の戦略・SWOT・財務情報
    Bank Saint Petersburg - Strategy, SWOT and Corporate Finance Report Summary Bank Saint Petersburg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • U-Shin Ltd.:企業の戦略的SWOT分析
    U-Shin Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Haemonetics Corp (HAE)-医療機器分野:企業M&A・提携分析
    Summary Haemonetics Corp (Haemonetics) is a healthcare company, which offers blood management technology and software solutions. The company’s portfolio consists of integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehe …
  • WABCO Holdings Inc.:戦略・SWOT・企業財務分析
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sun Pharma Advanced Research Company Ltd (SPARC)-製薬・医療分野:企業M&A・提携分析
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd is a pharma research and drug discovery company that conducts research and and produces drugs. The company develops active pharmaceutical ingredients, formulations and drug delivery technologi …
  • Insperity, Inc. (NSP):企業の財務・戦略的SWOT分析
    Insperity, Inc. (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SPR Coffee:企業の戦略・SWOT・財務情報
    SPR Coffee - Strategy, SWOT and Corporate Finance Report Summary SPR Coffee - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Verisk Analytics, Inc.:企業の戦略・SWOT・財務情報
    Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Verisk Analytics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sejal Glass Limited (SEZAL):企業の財務・戦略的SWOT分析
    Sejal Glass Limited (SEZAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • El Paso Electric Company:企業の発電所・SWOT分析2018
    El Paso Electric Company - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • GS Yuasa Corp (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corp (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wintac Ltd (524758):製薬・医療:M&Aディール及び事業提携情報
    Summary Wintac Ltd (Wintac), formerly Recon Ltd is a manufacturer and marketer of sterile products. The company offers opthalmic products such as anti-glaucoma, anti-cholinergic, artificial tear, NSAID, steroids and combination, anti-infective, decongestant, anti allergic eye drops and nasal drop, a …
  • Sotera Health LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Venture Life Group Plc (VLG):製薬・医療:M&Aディール及び事業提携情報
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The groups product and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, medical devices for improving minor aches and pains, dry eyes and itchy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆